EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)

Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24)

Constance Thibault, Aude Fléchon, Laurence Albiges, Charlotte Joly, Philippe Barthelemy, Marine Gross-Goupil, Christine Chevreau, Elodie Coquan, Frédéric Rolland, Brigitte Laguerre, Gwenaelle Gravis, Nicolas Pécuchet und 7 weitere

European Journal of Cancer · 2023-06 · 186 · 83-90

DOI: 10.1016/j.ejca.2023.03.018 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift European Journal of Cancer, 2023-06. Verfasst von Constance Thibault und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, APHP-Centre, Université Paris Cité, Paris, France…. Hauptthemen laut MEDLINE: Carcinoma, Medullary, Carcinoma, Renal Cell, Kidney Neoplasms, Hypertension. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Roche, Unicancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, MedullaryCarcinoma, Renal CellKidney NeoplasmsHypertensionHumansBevacizumabGemcitabinePlatinumProspective StudiesRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsKidney

Stichwörter der Autor:innen

AdultBevacizumabChemotherapyCollecting duct carcinomaRare tumoursRenal medullary carcinoma (RMC)

Substanzen

BevacizumabGemcitabinePlatinum

Autor:innen und Institutionen

  • Department of Medical Oncology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, APHP-Centre, Université Paris Cité, Paris, France; Université Paris Cité, AP-HP, Centre de Recherche des Cordeliers INS…
  • Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Department of Medical Oncology, Gustave Roussy, Université Paris-Saclay, Gustave Roussy, Villejuif, France.
  • Department of Medical Oncology, Hôpital Henri Mondor, Créteil, France.
  • Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.
  • Department of Medical Oncology, Centre hospitalo-Universitaire, Bordeaux, France.

Förderung

  • Roche
  • Unicancer

Zitieren

APA

Thibault, C., Fléchon, A., Albiges, L., Joly, C., Barthelemy, P., Gross-Goupil, M., Chevreau, C., Coquan, E., Rolland, F., Laguerre, B., Gravis, G., Pécuchet, N., Elaidi, R. T., Timsit, M. O., Brihoum, M., Auclin, E., de Reyniès, A., Allory, Y., & Oudard, S. (2023). Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24). European Journal of Cancer, 186, 83-90. https://doi.org/10.1016/j.ejca.2023.03.018

Vancouver

Thibault C, Fléchon A, Albiges L, Joly C, Barthelemy P, Gross-Goupil M, et al. Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24). European Journal of Cancer. 2023;186:83-90. doi:10.1016/j.ejca.2023.03.018

BibTeX
@article{Thibault2023,
  author = {Thibault, Constance and Fléchon, Aude and Albiges, Laurence and Joly, Charlotte and Barthelemy, Philippe and Gross-Goupil, Marine and Chevreau, Christine and Coquan, Elodie and Rolland, Frédéric and Laguerre, Brigitte and Gravis, Gwenaelle and Pécuchet, Nicolas and Elaidi, Réza-Thierry and Timsit, Marc-Olivier and Brihoum, Meryem and Auclin, Edouard and de Reyniès, Aurélien and Allory, Yves and Oudard, Stéphane},
  title = {Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24)},
  journal = {European Journal of Cancer},
  year = {2023},
  volume = {186},
  pages = {83--90},
  doi = {10.1016/j.ejca.2023.03.018}
}
Kostenlos starten →